---
Helicobacter, Ahead of Print. (Source: Helicobacter)
Source: Helicobacter - March 4, 2018 Category: Gastroenterology Source Type: research
Brief report: Lactobacillus bulgaricus GLB44 (Proviotic ™) plus esomeprazole for Helicobacter pylori eradication: A pilot study
ConclusionWe were unable to confirm reports of achieving a high H. pylori cure rate with L. delbrueckii GLB44 plus a PPI. (Source: Helicobacter)
Source: Helicobacter - March 4, 2018 Category: Gastroenterology Authors: Antone R. Opekun, Savannah A. Gonzales, Mahmoud A. Al ‐Saadi, David Y. Graham Tags: ORIGINAL ARTICLE Source Type: research
Editorial: Helicobacter pylori and gastric cancer in Alaskan Natives: Time to stop studying H. pylori and to eradicate it
Helicobacter,Volume 23, Issue 3, June 2018. (Source: Helicobacter)
Source: Helicobacter - March 2, 2018 Category: Gastroenterology Authors: Yi ‐Chia
Lee
,
Masahiro
Asaka
,
David Y.
Graham Source Type: research
Helicobacter pylori and gastric cancer in Alaskan Natives: Time to stop studyingH. pylori and to eradicate it
Helicobacter, EarlyView. (Source: Helicobacter)
Source: Helicobacter - March 2, 2018 Category: Gastroenterology Source Type: research
---
Helicobacter, Ahead of Print. (Source: Helicobacter)
Source: Helicobacter - March 2, 2018 Category: Gastroenterology Source Type: research
Monotherapy with a novel intervenolin derivative, AS ‐1934, is an effective treatment for Helicobacter pylori infection
Helicobacter,Volume 23, Issue 2, April 2018. (Source: Helicobacter)
Source: Helicobacter - February 28, 2018 Category: Gastroenterology Source Type: research
---
Helicobacter, Ahead of Print. (Source: Helicobacter)
Source: Helicobacter - February 28, 2018 Category: Gastroenterology Source Type: research
Age and gender may be the key points in hyperglycemic patients with Helicobacter pylori infection combined colorectal adenoma
Helicobacter,Volume 23, Issue 2, April 2018. (Source: Helicobacter)
Source: Helicobacter - February 26, 2018 Category: Gastroenterology Source Type: research
High prevalence of Helicobacter pylori clarithromycin resistance mutations among Seattle patients measured by droplet digital PCR
Helicobacter,Volume 23, Issue 2, April 2018. (Source: Helicobacter)
Source: Helicobacter - February 26, 2018 Category: Gastroenterology Source Type: research
Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta ‐analysis
Helicobacter,Volume 23, Issue 2, April 2018. (Source: Helicobacter)
Source: Helicobacter - February 26, 2018 Category: Gastroenterology Source Type: research
---
Helicobacter, Ahead of Print. (Source: Helicobacter)
Source: Helicobacter - February 26, 2018 Category: Gastroenterology Source Type: research
Furazolidone treatment for Helicobacter Pylori infection: A systematic review and meta ‐analysis
Abstract
Antibiotic resistance is a major cause of Helicobacter pylori (H. pylori) treatment failures. Because the resistance rate of H. pylori to furazolidone is low, we aimed to assess the efficacy and safety of furazolidone. We searched the PubMed, Web of Science, Cochrane Library, and Embase databases and included randomized controlled trials (RCT) that either compared furazolidone to other antibiotics or changed the administered dose of furazolidone. A total of 18 articles were included in the meta‐analysis. According to the intention‐to‐treat (ITT) analysis, the total eradication rates of furazolidone‐conta...
Source: Helicobacter - February 26, 2018 Category: Gastroenterology Authors: Liya Zhuge, Youhua Wang, Shuang Wu, Ru ‐Lin Zhao, Zhen Li, Yong Xie Tags: REVIEW ARTICLE Source Type: research
